Long-Acting Injectable HIV Treatment and PrEP

New England AETC Local Partner

(Recorded 3/4/22)

Training program on new long-acting HIV injectable Cabotegravir for PrEP and Cabotegravir/Rilpivirine for treatment. Dr. Amy Colson addresses efficacy, benefits and challenges of long-acting injectables, where and how to administer, dosing schedules, and comparisons to oral medication.


Amy Colson, MD
Research Director
Community Research Initiative

Browse more